Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia. [electronic resource]
Producer: 20000531Description: 461-9 p. digitalISSN:- 0277-0008
- Administration, Oral
- Amoxicillin-Potassium Clavulanate Combination -- economics
- Anti-Bacterial Agents -- economics
- Anti-Infective Agents -- economics
- Antitubercular Agents -- economics
- Azithromycin -- economics
- Cefaclor -- economics
- Clarithromycin -- economics
- Community-Acquired Infections -- drug therapy
- Cost-Benefit Analysis
- Erythromycin -- economics
- Fluoroquinolones
- Humans
- Models, Economic
- Outpatients -- statistics & numerical data
- Pneumonia -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.